Aminoglycoside breakpoints – the EUCAST approach and what this means for the clinician.
C. Giske et al., Clin. Microbiol. Inf. 2025.
Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review (CMI 2025).
J. Turnidge et al., Clinical Microbiology and Infection, 2025.
Corynebacterium diphtheriae and Corynebacterium ulcerans: development of EUCAST methods and generation of data on which to determine breakpoints.
A. Berger et al., J. Antimicrob. Chemother. 2024.
European multi-centre study to establish MIC and zone diameter epidemiological cut-off values for Bacillus anthracis.
F. Dematheis et al., 2024.
New CLSI and EUCAST harmonized procedure for selecting optimal disk contents for disk diffusion testing
EUCAST disk diffusion testing of anaerobic bacteria – Expanding the range of antimicrobial agents
Corynebacterium diphtheriae and C. ulcerans – Development of clinical breakpoints using EUCAST methodology
Toxigenic and non-toxigenic Vibrio cholerae can share the same MIC breakpoints.
Robust statistical tool for defining antimicrobial inhibition zone diameter wild-type distributions and calculating ECOFFs
Vibrio species: development of EUCAST susceptibility testing methods and MIC and zone diameter distributions on which to determine clinical breakpoints
O. Karatuna et al., J. Antimicrob. Chemother. 2023.
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values-laboratory and clinical utility
G. Kahlmeter and J. Turnidge, Clin. Microbiol. Rev. 2023
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution
G.Fröberg et al., Clin. Microbiol. Inf. 2023
The European committee on antimicrobial susceptibility testing disc diffusion susceptibility testing method for frequently isolated anaerobic bacteria
E. Matuschek et al., Cli. Microbiol. Inf. 2023.
Evaluation of prolonged incubation time of 16-20 h with the EUCAST rapid antimicrobial susceptibility disc diffusion testing method
E. Jonasson et al., J. Antimicrob. Chemother. 2023.
Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method
A.Tscherne et al., Microorganisms. 2022.
Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing
E. Matuschek et al., J. Antimicrob. Chemother. 2022.
How to: ECOFFs – the why, the how and the don´ts of EUCAST epidemiological cutoff values
G. Kahlmeter and J. Turnidge. Clin. Microbiol. Inf. 2022.
Evaluation of 10 brands of pre-poured Mueller Hinton agar plates for EUCAST disk diffusion
J. Åhman et al. Clin. Microbiol. Inf. 2022.
Microbiological Epidemiology of Invasive Infections Due to Non-Beta-Hemolytic Streptococci, France, 2021
C. Giske et al., J. Antimicrob. Chemother. 2021.
Revisiting colistin susceptibility testing: Will adding calcium to Mueller-Hinton agar improve the detection of colistin resistance
E. Matuschek et al., 2021.
Development of a EUCAST disk diffusion method for the susceptibility testing of rapidly growing anaerobic bacteria using Fastidious Anaerobe Agar (FAA) - Development study using Bacteroides species
H. Bavelaar et al., Clin. Microbiol. Inf. 2021.
Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study
C. Giske et al., J. Antimicrob. Chemother. 2021.
Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off values
O Karatuna et al., ., Clin. Microbiol. Inf. 2021.
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
J. Turnidge, et al., Clin. Microbiol. Inf. 2020.
EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories
A. Åkerlund et al., J. Antimicrob. Chemother. 2020.
EUCAST evaluation of 21 brands of Mueller-Hinton dehydrated media for disk diffusion testing
J. Åhman et al. Clin. Microbiol. Inf. 2020.
E. Jonasson et al., J. Antimicrob. Chemother. 2019.
The quality of antimicrobial discs from nine manufacturers - EUCAST evaluations in 2014 and 2017
J. Åhman et al. Clin. Microbiol. Inf. 2019
1st report in CMI from the EUCAST Subcommittee on the role of whole genome sequencing in antimicrobial susceptibility testing
M. J. Ellington et al., Clin. Microbiol. Inf. 2015.
EUCAST – are we heading towards international agreement?
The Garrod Lecture. G. Kahlmeter. J. Antimicrob. Chemother. 2015.
Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe
D. Brown et al., Eurosurveillance, 2015.
EUCAST Disk Diffusion Method
E. Matuschek et al., J. Clin. Microbiol. Inf. 2013.
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints - the EUCAST approach.
J.W. Mouton et al., J. Clin. Microbiol. Inf. 2012.
EUCAST Expert rules in antimicrobial susceptibility testing
R. Leclercq et al., J. Clin. Microbiol. Inf. 2012.
Editorial - EUCAST technical notes on antimicrobial susceptibility testing
Kahlmeter G, Brown DFJ, Goldstein FW, et al. Editorial: European Committee on Antimicrobial Susceptibility Testing (EUCAST). CMI 2006; 12:501-503.
Harmonisation of antimicrobial breakpoints in Europe – can it be achieved?
Kahlmeter G, Brown DFJ. (2004) Harmonisation of antimicrobial breakpoints in Europe – can it be achieved?. Clinical Microbiology Newsletter 2004; 26:187-192.
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria, 2003
Kahlmeter G, Brown DFJ, Goldstein FW et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003; 52:145-148.
Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution, March 2003
European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Discussion Document E. Dis 5.1: determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infec 2003; 9 (insert): 1-7.
This discussion document was not developed into a EUCAST definitive document because EUCAST was aware of the proposed development of an international (ISO) standard for broth microdilution, which was eventually published in 2006.
Determination of antimicrobial susceptibility test breakpoints, Aug 2000
European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E. Def 2.1: determination of antimicrobial susceptibility test breakpoints. Clin Microbiol Infec 2000; 6:570-572.
Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution, Jun 2000
European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). EUCAST Definitive Document E. Def 3.1: determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infec 2000; 6:509-515.
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents, May 2000
EUCAST Definitive Document E.Def 1.2: terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infec 2000; 6:503-508.
Looking for more information? Get in touch with an EUCAST representative today!
We’ve prepared a short video to help you get familiar with the new layout and features.